Noble Wealth Management PBC’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11K Buy
+3
New +$896 ﹤0.01% 686

Other funds holding KRYS

Noble Wealth Management PBC's KRYS Position: Q2 2026 in Review

Noble Wealth Management PBC opened a new position in Krystal Biotech (KRYS) in Q2 2026: 3 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #686 among its holdings.

91 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Noble Wealth Management PBC held 3 shares of Krystal Biotech worth $1.11K as of Q2 2026.
  • Krystal Biotech was a new Noble Wealth Management PBC position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #686 holding.
  • 91 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.